MedReleaf® is a Markham Ontario-based medical cannabis cultivator, and a subsidiary of Aurora®.
MedReleaf® is driven by research and development and invests heavily in medical cannabis research. The cultivator was the first Canadian Licensed Producer to achieve internationally recognized certifications including ISO 9001 ISO 14001 and OHSAS 18001.
MedReleaf®’s high-quality cannabis products are also cultivated in state-of-the-art EU-GMP and ISO 9001 certified facilities, which also produce products for the recreational brands San Rafael ’71 and AltaVie.
MedReleaf® products are strain-specific, meaning that all of MedReleaf®’s oils, softgels, and vape products are extracted from a single strain, and retain the same terpenes and cannabinoids from the original plant.
The popular MedReleaf® strains Avidekel, Midnight, Alaska and Eran Almog were first introduced to the Canadian marketplace by MedReleaf® in partnership with Tikun Olam, the highly respected Israel-based cannabis researcher and producer. MedReleaf® has since engineered Trutiva™, Equiposa™ and Orellium™ products to mimic the strains, genetics and qualities of some of the Tikun Olam strains at a lower price point for patients.